AIMS/HYPOTHESIS: Stearoyl-CoA desaturase (SCD) is emerging as a key regulator of lipid and carbohydrate metabolism. Scd-null mice display a beneficial metabolic phenotype characterised by resistance to obesity, diabetes and hyperlipidaemia. The human homologue, SCD, maps to a region of chromosome 10 linked to type 2 diabetes, and SCD activity correlates with insulin sensitivity. Given this strong positional and biological candidacy, the present study sought to establish whether sequence variation in SCD influences susceptibility to type 2 diabetes and related traits. METHODS: The SCD gene was resequenced in 23 diabetic subjects. Six variants within coding and adjacent sequence, including a non-synonymous SNP in exon 5 (M224L), were selected for genotyping in a primary set of 608 diabetic subjects and 600 control subjects. RESULTS: There was no association (at the allele, genotype or haplotype level) with type 2 diabetes, although genotype frequencies at the +14301 A>C SNP in the 3' untranslated region showed borderline association (p~0.06) when evidence for linkage was taken into account. However, replication studies (350 young-onset diabetic patients; 747 controls) failed to confirm any relationship with diabetes for this variant. No significant associations were seen for diabetes-related traits including BMI and waist-to-hip ratio. CONCLUSIONS/ INTERPRETATION: The present study, the first reported analysis of this gene, indicates that the SCD variants typed do not explain chromosome-10-encoded susceptibility to type 2 diabetes. Although this study provided no evidence that SCD sequence variation influences diabetes susceptibility or related traits, SCD remains a major target for pharmaceutical and/or environmental manipulation.
AIMS/HYPOTHESIS: Stearoyl-CoA desaturase (SCD) is emerging as a key regulator of lipid and carbohydrate metabolism. Scd-null mice display a beneficial metabolic phenotype characterised by resistance to obesity, diabetes and hyperlipidaemia. The human homologue, SCD, maps to a region of chromosome 10 linked to type 2 diabetes, and SCD activity correlates with insulin sensitivity. Given this strong positional and biological candidacy, the present study sought to establish whether sequence variation in SCD influences susceptibility to type 2 diabetes and related traits. METHODS: The SCD gene was resequenced in 23 diabetic subjects. Six variants within coding and adjacent sequence, including a non-synonymous SNP in exon 5 (M224L), were selected for genotyping in a primary set of 608 diabetic subjects and 600 control subjects. RESULTS: There was no association (at the allele, genotype or haplotype level) with type 2 diabetes, although genotype frequencies at the +14301 A>C SNP in the 3' untranslated region showed borderline association (p~0.06) when evidence for linkage was taken into account. However, replication studies (350 young-onset diabeticpatients; 747 controls) failed to confirm any relationship with diabetes for this variant. No significant associations were seen for diabetes-related traits including BMI and waist-to-hip ratio. CONCLUSIONS/ INTERPRETATION: The present study, the first reported analysis of this gene, indicates that the SCD variants typed do not explain chromosome-10-encoded susceptibility to type 2 diabetes. Although this study provided no evidence that SCD sequence variation influences diabetes susceptibility or related traits, SCD remains a major target for pharmaceutical and/or environmental manipulation.
Authors: R Duggirala; J Blangero; L Almasy; T D Dyer; K L Williams; R J Leach; P O'Connell; M P Stern Journal: Am J Hum Genet Date: 1999-04 Impact factor: 11.025
Authors: James M Ntambi; Makoto Miyazaki; Jonathan P Stoehr; Hong Lan; Christina M Kendziorski; Brian S Yandell; Yang Song; Paul Cohen; Jeffrey M Friedman; Alan D Attie Journal: Proc Natl Acad Sci U S A Date: 2002-08-12 Impact factor: 11.205
Authors: Chikh Bengra; Theodore E Mifflin; Yuri Khripin; Paolo Manunta; Scott M Williams; Pedro A Jose; Robin A Felder Journal: Clin Chem Date: 2002-12 Impact factor: 8.327
Authors: S Ghosh; R M Watanabe; T T Valle; E R Hauser; V L Magnuson; C D Langefeld; D S Ally; K L Mohlke; K Silander; K Kohtamäki; P Chines; J Balow; G Birznieks; J Chang; W Eldridge; M R Erdos; Z E Karanjawala; J I Knapp; K Kudelko; C Martin; A Morales-Mena; A Musick; T Musick; C Pfahl; R Porter; J B Rayman Journal: Am J Hum Genet Date: 2000-10-13 Impact factor: 11.043
Authors: José López-Miranda; Pablo Pérez-Martínez; Carmen Marin; Francisco Fuentes; Javier Delgado; Francisco Pérez-Jiménez Journal: J Mol Med (Berl) Date: 2006-12-15 Impact factor: 4.599
Authors: Dominick J Lemas; Yann C Klimentidis; Stella Aslibekyan; Howard W Wiener; Diane M O'Brien; Scarlett E Hopkins; Kimber L Stanhope; Peter J Havel; David B Allison; Jose R Fernandez; Hemant K Tiwari; Bert B Boyer Journal: Mol Nutr Food Res Date: 2016-09-15 Impact factor: 5.914
Authors: H Melhus; U Risérus; E Warensjö; L Wernroth; K Jensevik; L Berglund; B Vessby; K Michaëlsson Journal: Osteoporos Int Date: 2007-12-08 Impact factor: 4.507
Authors: Maria Arregui; Brian Buijsse; Norbert Stefan; Dolores Corella; Eva Fisher; Romina di Giuseppe; Oscar Coltell; Sven Knüppel; Krasimira Aleksandrova; Hans-Georg Joost; Heiner Boeing; Cornelia Weikert Journal: PLoS One Date: 2012-11-06 Impact factor: 3.240
Authors: Zhihua Jiang; Jennifer J Michal; David J Tobey; Tyler F Daniels; Daniel C Rule; Michael D Macneil Journal: Int J Biol Sci Date: 2008-09-25 Impact factor: 6.580